Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

297
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
297
Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

432
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
432
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

5.7K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
5.7K
Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

343
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
343
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

2.5K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.5K
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

5.4K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuronal silence as a predictive biomarker and target for epileptic seizures suppression.

Scientific reports·2026
Same author

Dependence of isochronous bifurcations on the driving-mode phase shift in two-harmonic standard maps.

Physical review. E·2025
Same author

Collapse of multi-headed chimera states in biologically based neuronal networks.

Chaos (Woodbury, N.Y.)·2025
Same author

Dynamic behavior analysis of a fractal tumor-immune model with drug resistance.

Physical review. E·2025
Same author

Arnold tongues replace period-doubling cascades in a memristor circuit.

Chaos (Woodbury, N.Y.)·2025
Same author

Two-player Yorke's game of survival in chaotic transients.

Physical review. E·2025

Related Experiment Video

Updated: Feb 27, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.2K

The dose-dense principle in chemotherapy.

Álvaro G López1, Kelly C Iarosz2, Antonio M Batista3

  • 1Nonlinear Dynamics, Chaos and Complex Systems Group, Departamento de Física, Universidad Rey Juan Carlos, Tulipán s/n, 28933 Móstoles, Madrid, Spain.

Journal of Theoretical Biology
|July 11, 2017
PubMed
Summary

Mathematical analysis reveals a maximum time between chemotherapy cycles for effective cancer treatment. Results support dose-dense chemotherapy protocols, optimizing treatment efficacy and patient outcomes.

More Related Videos

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
04:48

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

7.8K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.3K

Related Experiment Videos

Last Updated: Feb 27, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.2K
Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
04:48

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

7.8K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.3K

Area of Science:

  • Oncology
  • Mathematical Biology
  • Pharmacokinetics

Background:

  • Chemotherapy is a cornerstone of cancer treatment, utilizing cytotoxic drugs to eliminate tumor cells.
  • Standard chemotherapy protocols often involve cyclical administration of multiple drugs over a three-week schedule.
  • Optimizing chemotherapy scheduling is crucial for maximizing therapeutic benefit and minimizing treatment resistance.

Purpose of the Study:

  • To mathematically determine the maximum allowable time between chemotherapy cycles for sustained treatment efficacy.
  • To derive an equation correlating optimal inter-cycle timing with tumor kinetics and drug treatment parameters.
  • To evaluate the implications of these findings for current chemotherapy dosing strategies, particularly dose-dense protocols.

Main Methods:

  • Development and analysis of mathematical models simulating tumor growth and chemotherapy effects.
  • Derivation of an equation defining the critical time interval between chemotherapy cycles.
  • Inclusion of parameters representing tumor cell proliferation, drug-induced cell death, and treatment scheduling.

Main Results:

  • Demonstration of a theoretical maximum time interval between chemotherapy cycles beyond which efficacy is compromised.
  • A derived mathematical equation quantifies this maximum interval based on tumor and treatment variables.
  • Findings provide quantitative support for the clinical benefits of dose-dense chemotherapy regimens.

Conclusions:

  • Mathematical modeling confirms the existence of critical timing constraints in chemotherapy protocols.
  • The derived equation offers a framework for optimizing chemotherapy scheduling to enhance tumor cell kill.
  • Results advocate for dose-dense chemotherapy, while acknowledging potential limitations and suggesting alternative approaches for further investigation.